[Use of a isoniozid-rifompicin drug hepatotoxicity screening technic in tuberculosis therapy].
D000328:Adult; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000517:prevention & control*; D004796:Clinical Enzyme Tests; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007527:Isoenzymes; D007538:Isoniazid / Q000009:adverse effects* / Q000627:therapeutic use; D007565:Jaundice / Q000139:chemically induced / Q000175:diagnosis; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D010088:Oxidoreductases / Q000097:blood; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D000637:Transaminases / Q000097:blood; D014376:Tuberculosis / Q000188:drug therapy*
D007527:Isoenzymes; D010088:Oxidoreductases; D007770:L-Lactate Dehydrogenase; D000637:Transaminases; D001663:Bilirubin; D007538:Isoniazid; D012293:Rifampin
Application de la méthode de épistage d'hépathotoxite médicamenteuse a l'assocation isoniazide-rifampicine dans le traitement de la ruberculose